Efectos del café en la salud: una perspectiva desde la niñez hasta la adultez

Daniel Arboleda Palacios, Hulizay Paola Álzate Hernández, Lina Marcela Ortiz Roncallo, Lucia Uribe Restrepo, María Esther Puchana Quintero

Resumen


Introducción: El café es una de las bebidas más consumidas a nivel mundial, con un grupo de componentes, dentro de los cuales la cafeína, una metilxantina se asocia a la mayoría de efectos generados en la salud.  La presente revisión sistemática pretende resumir la información disponible en la literatura, acerca de los efectos positivos y negativos asociados al consumo de esta bebida a nivel del sistema cardiovascular, metabólico, neurológico, cáncer, gestación e infancia.

Objetivo: Describir los principales efectos, tanto positivos como negativos, asociados al consumo de café en las distintas etapas del ciclo de desarrollo.

Metodología: Se identificó información relevante dentro del periodo comprendido entre  junio de 2019 y agosto de 2020 registrada en las principales bases de datos: Pubmed, SCOPUS, MEDLINE, Cochrane, SCIENCE DIRECT y Google scholar, acerca de los efectos positivos y negativos asociados al consumo de café en la edad adulta, infancia y embarazo. Se revisaron un total de 412 artículos, de los cuales se seleccionaron 40, los cuales mencionan efectos a nivel cardiovascular, neurológico, metabólico, cáncer, embarazo, feto e infancia.

Conclusión: El consumo del café es seguro e incluso puede llegar a tener efectos benéficos para la salud, sin embargo, el mismo debe individualizarse según la condición médica de cada paciente.


Palabras clave


Café, cafeína, consumo, salud, embarazo, niños.

Texto completo:

PDF

Referencias


Fredholm BB. Notes on the history of caffeine use. Handb Exp Pharmacol. 2011;200:1–9.

Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev. 2014;2017(10).

de Melo Pereira G V., de Carvalho Neto DP, Magalhães Júnior AI, do Prado FG, Pagnoncelli MGB, Karp SG, et al. Chemical composition and health properties of coffee and coffee by-products [Internet]. 1st ed. Vol. 91, Advances in Food and Nutrition Research. Elsevier Inc.; 2020. 65–96 p. Available from: http://dx.doi.org/10.1016/bs.afnr.2019.10.002

Kossel A. Ueber eine neue Base aus dem Pflanzenreich. Berichte der Dtsch Chem Gesellschaft. 1888;21(1):2164–7.

Schultze‐Werninghaus g, Meier‐Sydow j. The clinical and pharmacological history of theophylline: first report on the bronchospasmolytic action in man by S. R. Hirsch in Frankfurt (Main) 1922. Clin Exp Allergy. 1982;12(2):211–5.

Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al.

Long-Term Effects of Caffeine Therapy for Apnea of Prematurity. N Engl J

Med. 2007;357(19):1893–902.

Van Dam RM, Hu FB, Willett WC. Coffee, caffeine, and health. N Engl J Med. 2020;383(4):369–78.

Chen LW, Wu Y, Neelakantan N, Chong MFF, Pan A, van Dam RM. Maternal caffeine intake during pregnancy is associated with risk of low birth weight: A systematic review and dose-response meta-analysis. BMC Med. 2014;12(1):1–12.

Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother. 2002;36(6):992–5.

Willson C. The clinical toxicology of caffeine: A review and case study. Toxicol Reports [Internet]. 2018;5:1140–52. Available from: https://doi.org/10.1016/j.toxrep.2018.11.002

Kot M, Daniel WA. Caffeine as a marker substrate for testing cytochrome P450 activity in human and rat. Pharmacol Rep. 2008;60:789–797.

Begas, E., Kouvaras, E., Tsakalof, A., Papakosta, S., & Asprodini, E. K. (2007). In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Biomedical Chromatography, 21(2), 190–200. doi:10.1002/bmc.736

Kalow W, Tang B ‐K. The use of caffeine for enzyme assays: A critical appraisal. Clin Pharmacol Ther. 1993;53(5):503–14.

Kot M, Daniel WA. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: An in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem Pharmacol. 2008;76(4):543–51.

Galli E, Feijoó L. Citocromo P-450 y su importancia clínica: revisión actualizada. Revista de Neuro-Psiquiatria. 2013; 65 (3-4): 187-201.

Goyan JE: Food and Drug Administration, news release No. P80-36. Washington, DC: FDA, September 4, 1980.

Grosso LM, Bracken MB. Caffeine Metabolism, Genetics, and Perinatal Outcomes: A Review of Exposure Assessment Considerations during Pregnancy. Annals of Epidemiology. 2005;15(6):460–6.

Choi H, Koo S, Park H-Y. Maternal coffee intake and the risk of bleeding in early pregnancy: a cross-sectional analysis. BMC Pregnancy and Childbirth. 2020;20(1).

Cnattingius S, Signorello LB, Annerén G, Clausson B, Ekbom A, Ljunger E, et al. Caffeine Intake and the Risk of First-Trimester Spontaneous Abortion. Obstet Gynecol Surv. 2001;56(5):259–60.

Fenster L, Eskenazi B, Windham GC, Swan SH. Caffeine consumption during pregnancy and fetal growth. Am J Public Health. 1991;81(4):458–61.

Wilcox A. Caffeinated Beverages And Decreased Fertility. The Lancet. 1989;333(8642):840.

Restricting caffeine intake during pregnancy [Internet]. World Health Organization. 2020 [cited 1 October 2020]. Available from: https://bit.ly/37ElOu5

Lyngsø J, Ramlau-Hansen CH, Bay B, Ingerslev HJ, Hulman A, Kesmodel US. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose–response meta-analysis. Clinical Epidemiology. 2017;Volume 9:699–719.

Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. Bmj. 2008;337(nov03 2).

Qian J, Chen Q, Ward SM, Duan E, Zhang Y. Impacts of Caffeine during Pregnancy. Trends Endocrinol Metab [Internet]. 2020;31(3):218–27. Available from: https://doi.org/10.1016/j.tem.2019.11.004

Temple JL. Caffeine use in children: What we know, what we have left to learn, and why we should worry. Neuroscience & Biobehavioral Reviews. 2009;33(6):793–806.

Watson EJ, Banks S, Coates AM, Kohler MJ. The relationship between caffeine, sleep, and behavior in children. J Clin Sleep Med. 2017;13(4):533–43.

Calamaro CJ, Yang K, Ratcliffe S, Chasens ER. Wired at a Young Age: The Effect of Caffeine and Technology on Sleep Duration and Body Mass Index in School-Aged Children. J Pediatr Heal Care [Internet]. 2012;26(4):276–82. Available from: http://dx.doi.org/10.1016/j.pedhc.2010.12.002

Luebbe AM, Bell DJ. Mountain dew ® or mountain don’t?: A pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students. J Sch Health. 2009;79(8):380–7.

Benko CR, Farias AC, Farias LG, Pereira EF, Louzada FM, Cordeiro ML. Potential link between caffeine consumption and pediatric depression: A case-control study. BMC Pediatr. 2011;11.

Torres-ugalde YC, Romero-palencia A, Rom AD. Ca ff eine Consumption in Children : Innocuous or Deleterious ? A Systematic Review.

Doyle LW, Cheong J, Hunt RW, Lee KJ, Thompson DK, Davis PG, et al. Caffeine and brain development in very preterm infants. Ann Neurol. 2010;68(5):734–42.

Gray PH, Flenady VJ, Charles BG, Steer PA. Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour. J Paediatr Child Health. 2011;47(4):167–72.

Doyle LW, Schmidt B, Anderson PJ, Davis PG, Moddemann D, Grunau RE, et al. Reduction in developmental coordination disorder with neonatal caffeine therapy. J Pediatr [Internet]. 2014;165(2). Available from: http://dx.doi.org/10.1016/j.jpeds.2014.04.016

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388: 1545-602

Hindiyeh NA, Zhang N, Farrar M, Banerjee P, Lombard L, Aurora SK. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review. Headache: The Journal of Head and Face Pain. 2020;60(7):1300–16.

Baratloo A, Rouhipour A, Forouzanfar MM, Safari S, Amiri M, Negida A. The Role of Caffeine in Pain Management: A Brief Literature Review. Anesthesiology and Pain Medicine. 2016;6(3).

Sawynok J. Caffeine and pain. Pain. 2011;152(4):726–9.

Guieu, R .; Devaux, C .; Henry, H .; Bechis, G .; Pouget, J .; Mallet, D .; Sampieri, F .; Juin, M .; Gola, R .; Rochat, H. Adenosine y migraña. Lata. J. Neurol. Sci. 1998 , 25 , 55–58

Arzani, M .; Jahromi, SR; Ghorbani, Z .; Vahabizad, F .; Martelletti, P .; Ghaemi, A .; Sacco, S .; Togha, M .; En nombre de la Escuela de Estudios Avanzados de la Federación Europea de Dolor de Cabeza (EHF-SAS). Eje intestino-cerebral y migraña: una revisión completa. J. Dolor de cabeza 2020 , 21 , 15

Camboim Rockett F, Castro K, Rossoni de Oliveira V, da Silveira Perla A, Fagundes Chaves ML, Schweigert Perry ID. Factores desencadenantes de migraña; ¿los factores dieteticos tienen influencia? Nutr Hosp. 2012;27(2):483–9.

Aguggia M, Saracco MG. Pathophysiology of migraine chronification. Neurological Sciences. 2010;31(S1):15–7.

Kirkland A, Sarlo G, Holton K. The Role of Magnesium in Neurological Disorders. Nutrients. 2018;10(6):730.

Nowaczewska M, Wiciński M, Kaźmierczak W. The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment. Nutrients. 2020;12(8):2259.

Enfermedades cardiovasculares [Internet]. Organización Mundial de la Salud. 2020 [cited 29 September 2020]. Available from: https://www.who.int/cardiovascular_diseases/es/

Yusuf S, Hawken S, Ounpuu S. Effect Of Potentially Modifiable Risk Factors Associated With Myocardial Infarction In 52 Countries (The Interheart Study). Journal of Cardiopulmonary Rehabilitation. 2005;25(1):56–7.

EFSA opinion on the safety of caffeine [Internet]. EFSA opinion on the safety of caffeine: (EUFIC). [cited 2020Nov1]. Available from: https://bit.ly/37BFmPG

Ding M, Bhupathiraju SN, Satija A, Dam RMV, Hu FB. Long-Term Coffee Consumption and Risk of Cardiovascular Disease. Circulation. 2014;129(6):643–59.

Shah SA, Chu BW, Lacey CS, Riddock IC, Lee M, Dargush AE. Impact of Acute Energy Drink Consumption on Blood Pressure Parameters. Annals of Pharmacotherapy. 2016;50(10):808–15.

D’Elia L, Fata EL, Galletti F, Scalfi L, Strazzullo P. Coffee consumption and risk of hypertension: a dose–response meta-analysis of prospective studies. European Journal of Nutrition. 2017;58(1):271–80.

Xie C, Cui L, Zhu J, Wang K, Sun N, Sun C. Coffee consumption and risk of hypertension: a systematic review and dose–response meta-analysis of cohort studies. Journal of Human Hypertension. 2018;32(2):83–93.

Giuseppe RD, Napoli ID, Granata F, Mottolese A, Cena H. Caffeine and blood pressure: a critical review perspective. Nutrition Research Reviews. 2019;32(2):169–75.

Miranda AM, Steluti J, Norde MM, Fisberg RM, Marchioni DM. The association between genetic risk score and blood pressure is modified by coffee consumption: Gene–diet interaction analysis in a population-based study. Clinical Nutrition. 2019;38(4):1721–8.

Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):439–58.

Markus HS. Stroke genetics. Hum Mol Genet. 2011;20(R2):124–31.

O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet [Internet]. 2016;388(10046):761–75. Available from: http://dx.doi.org/10.1016/S0140-6736(16)30506-2

Larsson SC, Männistö Satu, Virtanen MJ, Kontto J, Albanes D, Virtamo J. Coffee and Tea Consumption and Risk of Stroke Subtypes in Male Smokers. Stroke. 2008;39(6):1681–7.

Lopez-Garcia E, Rodriguez-Artalejo F, Rexrode KM, Logroscino G, Hu FB, Van Dam RM. Coffee consumption and risk of stroke in women. Circulation. 2009;119(8):1116–23.

Mostofsky E, Schlaug G, Mukamal KJ, Rosamond WD, Mittleman MA. Coffee and acute ischemic stroke onset: The Stroke Onset Study. Neurology. 2010;75(18):1583–8.

Qian Y, Ye D, Huang H, Wu DJH, Zhuang Y, Jiang X, et al. Consumo de café y riesgo de accidente cerebrovascular: un estudio de aleatorización mendeliana. Annals of Neurology. 2020; 87 (4): 525–32.

Bazal P, Gea A, Navarro A, Salas-Salvadó J, Corella D, Alonso-Gómez A, et al. Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts. European Journal of Preventive Cardiology. 2020;:204748732090906.

Krittanawong C, Tunhasiriwet A, Wang Z, Farrell AM, Chirapongsathorn S, Zhang H, et al. Is caffeine or coffee consumption a risk for new-onset atrial fibrillation? A systematic review and meta-analysis. European Journal of Preventive Cardiology. 2020;:204748732090838.

Voskoboinik A, Kalman JM, Kistler PM. Caffeine and Arrhythmias: Time to Grind the Data. JACC Clin Electrophysiol. 2018;4(4):425–32.

Lim Y, Park Y, Choi SK, Ahn S, Ohn JH. The effect of coffee consumption on the prevalence of diabetes mellitus: The 2012–2016 Korea national health and nutrition examination survey. Nutrients. 2019;11(10).

1. Pimentel GD, Zemdegs JC, Theodoro JA, Mota JF. Does long-term coffee intake reduce type 2 diabetes mellitus risk? Diabetol Metab Syndr. 2009;1(1):1–8.

Hang D, Zeleznik OA, He X, Guasch-Ferre M, Jiang X, Li J, et al. Metabolomic signatures of long-term coffee consumption and risk of type 2 diabetes in women. 2020;

Greer F, Hudson R, Ross R, Graham T. Caffeine Ingestion Decreases Glucose Disposal During a Hyperinsulinemic-Euglycemic Clamp in Sedentary Humans. Diabetes. 2001;50(10):2349–54.

Keijzers GB, De Galan BE, Tack CJ, Smits P: La cafeína puede disminuir la sensibilidad a la insulina en los seres humanos. Diabetes Care 25 : 364 –369, 2002

Keys A. Atherosclerosis: a problem in newer Public Health. J Mt Sinai Hosp. 1953;20(2):118-39

Gofman JW, Young W, Tandy R. Ischemic Heart Disease, Atherosclerosis, and Longevity. Circulation. 1966;34(4):679–97.

Kannel WB. Cholesterol in the Prediction of Atherosclerotic Disease. Annals of Internal Medicine. 1979;90(1):85.

Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, Caffeine, and Health Outcomes: An Umbrella Review. Annual Review of Nutrition. 2017;37(1):131–56.

Robertson TM, Clifford MN, Penson S, Williams P, Robertson MD. Postprandial glycaemic and lipaemic responses to chronic coffee consumption may be modulated by CYP1A2 polymorphisms. British Journal of Nutrition. 2018;119(7):792–800.

Roshan H, Nikpayam O, Sedaghat M, Sohrab G. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial. British Journal of Nutrition. 2018;119(3):250–8.

Sarriá B, Martínez-López S, Sierra-Cinos JL, García-Diz L, Mateos R, Bravo-Clemente L. Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome. European Journal of Nutrition. 2016;57(1):269–78.

Wang A, Wang S, Zhu C, Huang H, Wu L, Wan X, et al. Coffee and cancer risk: A meta-analysis of prospective observational studies. Sci Rep [Internet]. 2016;6:1–13. Available from: http://dx.doi.org/10.1038/srep33711

Drinking coffee, mate, and very hot beverages. Lyon, France: International Agency for Research on Cancer, World Health Organization; 2019.

Inoue M, Tsugane S. Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms. Curr Nutr Rep. 2019;8(3):182–6.

1. Creed JH, Smith-Warner SA, Gerke TA, Egan KM. A prospective study of coffee and tea consumption and the risk of glioma in the UK Biobank. Eur J Cancer [Internet]. 2020;129:123–31. Available from: https://doi.org/10.1016/j.ejca.2020.01.012

Podoltsev NA, Wang X, Wang R, Hofmann JN, Liao LM, Zeidan AM, et al. Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study. International Journal of Cancer. 2020;147(4):948–57.

Cui W-Q, Wang S-T, Pan D, Chang B, Sang L-X. Caffeine and its main targets of colorectal cancer. World Journal of Gastrointestinal Oncology. 2020;12(2):149–72.

Micek A, Godos J, Lafranconi A, Marranzano M, Pajak A. Caffeinated and decaffeinated coffee consumption and melanoma risk: a dose-response meta-analysis of prospective cohort studies. International Journal of Food Sciences and Nutrition. 2017;69(4):417–26.

Caini S, Cattaruzza MS, Bendinelli B, Tosti G, Masala G, Gnagnarella P, et al. Erratum to: Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. European Journal of Nutrition. 2017;56(5):2005–.

Lafranconi A, Micek A, Paoli PD, Bimonte S, Rossi P, Quagliariello V, et al. Coffee Intake Decreases Risk of Postmenopausal Breast Cancer: A Dose-Response Meta-Analysis on Prospective Cohort Studies. Nutrients. 2018;10(2):112.

Chen X, Zhao Y, Tao Z, Wang K. Coffee consumption is associated with a lower risk of prostate cancer: a meta-analysis. 2020;

Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and Liver Cancer: A Review. Current Pharmaceutical Biotechnology. 2012;13(1):218–28.

Bravi F, Tavani A, Bosetti C, Boffetta P, Vecchia CL. Coffee and the risk of hepatocellular carcinoma and chronic liver disease. European Journal of Cancer Prevention. 2017;26(5):368–77

Bohn SK, Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Mol Nutr Food Res. 2014;58(5):915–30.

Nivukoski U, Niemelä M, Bloigu A, Bloigu R, Aalto M, Laatikainen T, et al. Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status. Plos One. 2019;14(6).

Santos ME, Protopopescu C, Sogni P, Yaya I, Piroth L, Bailly F, et al. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort). AIDS Behav. 2020;24(4):1069–84.

Hong CT, Chan L, Bai C-H. The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis. Nutrients. 2020;12(6):1860.

Tellone E, Galtieri A, Russo A, Ficarra S. Protective Effects of the Caffeine Against Neurodegenerative Diseases. Current Medicinal Chemistry. 2019;26(27):5137–51.

Yan R, Zhang J, Park H-J, Park ES, Oh S, Zheng H, et al. Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinsons disease and DLB. Proceedings of the National Academy of Sciences. 2018;115(51).

Shen H-Y, Chen J-F. Adenosine A2A Receptors in Psychopharmacology: Modulators of Behavior, Mood and Cognition. Current Neuropharmacology. 2009;7(3):195–206.

Jahrami H, Al-Mutarid M, Penson PE, Faris MEA-I, Saif Z, Hammad L. Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in Bahrain. Foods. 2020;9(4):473.

Kromhout M, Ottenheim NR, Giltay E, Numans M, Achterberg W. Caffeine and neuropsychiatric symptoms in patients with dementia: A systematic review. Experimental Gerontology. 2019;122:85–91.

Jahrami H, Al-Mutarid M, Penson PE, Faris MEA-I, Saif Z, Hammad L. Intake of Caffeine and Its Association with Physical and Mental Health Status among University Students in Bahrain. Foods. 2020;9(4):473.

Kimura Y, Suga H, Kobayashi S, Sasaki S. Intake of coffee associated with decreased depressive symptoms among elderly Japanese women: A multi-center cross-sectional study. Vol. 30, Journal of Epidemiology. 2020. 338–344 p.

Sajadi-Ernazarova KR, Anderson J, Dhakal A, et al. Abstinencia de cafeína. [Actualizado el 2 de junio de 2020]. En: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 enero-. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK430790/#

Ocallaghan F, Muurlink O, Reid N. Effects of caffeine on sleep quality and daytime functioning. Risk Management and Healthcare Policy. 2018;Volume 11:263–71.

Rodda S, Booth N, Mckean J, Chung A, Park JJ, Ware P. Mechanisms for the reduction of caffeine consumption: What, how and why. Drug and Alcohol Dependence. 2020;212:108024.


Enlaces de Referencia

  • Por el momento, no existen enlaces de referencia


Copyright (c) 2020 Revista Neuronum